Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New gel filler shows promise for wrinkle reduction

NCT ID NCT07618468

Symptom relief Sponsor: Estelab Clinic Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a gel-like implant (Algeness) to improve the look of wrinkles and other skin contour problems. 40 adults aged 30-65 with age-related skin changes took part. The main goal was to see if the implant reduced wrinkle severity on a standard scale. The study is complete, and results showed a meaningful improvement.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

40 people

The number who actually took part.

Started

Jun 2024

Finished

Apr 2025

Lead sponsor

A research network

The lead sponsor is a research network or cooperative group.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 70 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age between 30 and 65 years inclusive * Presence of signs of age-related facial skin changes (decreased turgor, elasticity, fine wrinkles, contour defects) * Signed informed voluntary consent * Willingness and ability to comply with study procedures and attend all scheduled visits Exclusion Criteria: * Age under 18 years * Individual intolerance or allergy to any component of the investigational device * Diagnosed tendency to keloid or hypertrophic scarring * Severe chronic diseases in the acute phase * Acute forms of dermatological diseases * Coagulation disorders * Treatment with medications affecting blood coagulation * Inflammatory or infectious processes in the injection zones * Diagnosed autoimmune pathologies * Pregnancy and lactation period * Filler injections in the same area within the past 12 months * Laser procedures or chemical peels within the past 3 months * Oncological diseases in history or at the time of inclusion * Participation in another clinical study within the past 3 months

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Facial wrinkles are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

lipodystrophy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Facial wrinkles Lipoatrophy Skin aging Soft tissue volume loss

Contacts and locations

Locations

  • Estelab Clinic (Clinical Base of FSBEI FPE Russian Medical Academy of Continuing Professional Education)

    Moscow, 119034, Russia

More trials for these conditions

Other studies related to the condition(s) this trial covers.